The Jacobs Institute Synchron Symposium

Attendees will learn how Synchron's brain machine interface device, the stentrode, allows paralyzed patients who cannot speak to use their throughts to control a digital device. They will hear the results of the device's early feasibility study and plans for the pivotal clinical trial in 2025. They will also be introduced to Synchron's Online Community where they can register and refer patients for more information and future trial opportunities.

Host or Publisher The Jacobs Institute